2005
DOI: 10.1001/archderm.141.9.1077
|View full text |Cite
|
Sign up to set email alerts
|

Special Considerations for Stage IV Melanoma During Pregnancy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2006
2006
2021
2021

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(13 citation statements)
references
References 13 publications
0
13
0
Order By: Relevance
“…In the past, most women diagnosed with metastatic melanoma during pregnancy have either delivered at term and had poor outcomes with mortality within 12 months from metastatic treatment refractory disease or opted for pregnancy termination. 7 There has been one previously published case report in which a woman was delivered prematurely at 28 weeks, received combination chemotherapy but died four months after delivery. Sadly, the baby died of septicemia at three months of age, a common complication of preterm delivery.…”
Section: Discussionmentioning
confidence: 99%
“…In the past, most women diagnosed with metastatic melanoma during pregnancy have either delivered at term and had poor outcomes with mortality within 12 months from metastatic treatment refractory disease or opted for pregnancy termination. 7 There has been one previously published case report in which a woman was delivered prematurely at 28 weeks, received combination chemotherapy but died four months after delivery. Sadly, the baby died of septicemia at three months of age, a common complication of preterm delivery.…”
Section: Discussionmentioning
confidence: 99%
“…However, the management of advanced disease (stage III and IV) during pregnancy can be quite a dilemma, as the prognosis for these patients is poor. Traditional chemotherapeutic agents have not been shown to signifi cantly increase in survival for these patients, and their use during pregnancy needs to be considered carefully due to potential for adverse fetal effect [ 76 ]. Interferon has also been used in this setting, although the potential for severe toxicity limits its use during pregnancy.…”
Section: Melanomamentioning
confidence: 99%
“…Examples are melanocytomas developed on congenital naevi, dysplastic naevi (33), naevi modified by pregnancy or oral contraception (34), naevi of subjects on growth hormone therapy (15), naevi under ultraviolet-light irradiation (35,36). It should be mentioned that some of these lesions mimick MM or are at risk for MM development (37). The possibility of a melanocytoma should be evoked in each single case.…”
Section: Triggered Melanocytic Naevi and Cutaneous Melanocytomasmentioning
confidence: 99%